Rchr
J-GLOBAL ID:202201021380808070
Update date: Feb. 12, 2025 Tanaka Tetsuhiro
タナカ テツヒロ | Tanaka Tetsuhiro
Affiliation and department: Job title:
Professor
Research field (1):
Nephrology
Research keywords (4):
Nephrology
, CKD
, anemia
, hypoxia
Research theme for competitive and other funds (25): - 2024 - 2027 尿毒素による細胞内代謝失調を標的とした高齢者の慢性腎臓病合併症の治療開発
- 2023 - 2027 尿毒素による細胞内代謝失調を標的とした高齢者の慢性腎臓病合併症の治療開発
- 2023 - 2026 Elucidation of renoprotective effects by pharmacological intervention into oxygen metabolism, using living renal cells from urine of diabetic kidney disease patients
- 2023 - 2026 低酸素誘導因子(HIF)2を介する新規腎保護メカニズムの解明
- 2020 - 2025 ヒストン修飾阻害薬GSKJ4による腎尿細管間質線維化の病態解明
- 2021 - 2024 Novel tubular homeostatic mechanism mediated by primary cilia
- 2023 - 2024 糖尿病の実態把握と発症予防・重症化予防のための研究
- 2020 - 2023 プロリン水酸化酵素阻害による尿細管虚血障害後の修復、再生機構
- 2018 - 2021 Molecular mechanism of organelle crosstalk on organ homeostasis in aging and disease
- 2018 - 2021 Elucidation of metabolic reprogramming in the kidney and development of novel therapeutic approaches utilizing HIF against kidney disease
- 2017 - 2020 Therapeutic intervention of CKD targeting cellular oxygen sensors
- 2016 - 2019 Development of Novel Therapy for Renal Diseases Targeting Macrophage Metabolic Reprogramming
- 2016 - 2018 Establishment of innovative culture system, kidney-on-chip, utilizing microdevice
- 2016 - 2018 Pathophysiological role of D-amino acid on proteostasis in the kidney
- 2015 - 2018 Epigenetic regulation of endoplasmic reticulum stress signal in aging of kidney
- 2015 - 2018 Metabolic Reprogramming and Hypoxic Memory in Kidney Disease
- 2015 - 2018 Mechanisms of maintenance of podocyte cytoskeletal structure against metabolic stress associated with diabetes and Development of novel therapeutic strategies
- 2016 - 2017 Development of novel therapeutic approaches targeting ATF6-mediated metabolic alteration
- 2014 - 2017 Regulation of hypoxia inducible genes in chronic kidney disease
- 2012 - 2015 Elucidation of the pathogenesis of kidney disease via epigenetic responses against hypoxia
- 2012 - 2015 Elucidation of the mechanisms of podocyte homeostasis and development of new therapeutic strategies against diabetic kidney disease
- 2010 - 2014 a role of HIF-3 in adjusting cellular hypoxia response and its implications in progressive renal disease
- 2009 - 2011 Elucidation of the pathophysiology of chronic kidney disease by comprehensive analysis of the hypoxia-responsive transcriptional network
- 2009 - 2011 Elucidation of the mechanisms underlying podocyte injury through endoplasmic reticulum stress and Development of novel therapeutic strategies for glomerular diseases
- 2008 - 2009 A role of dysregulated glycosylation of hypoxia-inducible factors in the pathogenesis of cardio-renal syndrome
Show all
Papers (174): -
Yusuke Ishizuka, Yuji Oe, Sosuke Kinomura, Saori Kin, Yuji Noguchi, Koichi Kikuchi, Mai Yoshida, Rui Makino, Koji Okamoto, Tasuku Nagasawa, et al. Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma Developing Renal AA Amyloidosis: A Case Report and Literature Review. Internal medicine (Tokyo, Japan). 2025
-
Nonoka Suzuki, Kaname Kojima, Silvia Malvica, Kenshi Yamasaki, Yoichiro Chikamatsu, Yuji Oe, Tasuku Nagasawa, Ekyu Kondo, Satoru Sanada, Setsuya Aiba, et al. Deep learning-based histopathological assessment of tubulo-interstitial injury in chronic kidney diseases. Communications medicine. 2025. 5. 1. 3-3
-
Volker H Haase, Tetsuhiro Tanaka, Mark J Koury. Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney disease. Hematology. American Society of Hematology. Education Program. 2024. 2024. 1. 409-418
-
Akiyo Sekimoto, Yoko Takaso, Haruka Saruyama, Masataka Ookawa, Mari Yamamoto, Takafumi Toyohara, Daisuke Saigusa, Tomoko Fukuuchi, Mayu Otsuka, Yui Fushiki, et al. Impacts of low birthweight on kidney development and intergenerational growth of the offspring. iScience. 2024. 27. 11. 111159-111159
-
Sota Oguro, Hiromitsu Tannai, Hideki Ota, Kazumasa Seiji, Hiroki Kamada, Yoshitaka Toyama, Kei Omata, Yuta Tezuka, Yoshikiyo Ono, Fumitoshi Satoh, et al. Role of radiologists in the diagnosis and management of adrenal disorders. Endocrine journal. 2024
more... MISC (172): -
石岡 広崇, 田中 哲洋. 【慢性腎臓病診療の最近の進歩】(各論2)腎性貧血. Vita. 2024. 41. 4. 37-43
-
今田 悠介, 田中 哲洋. 【貧血 内科医が知っておきたい診療のポイント】治療 実地医家に必要な知識 腎性貧血の治療薬 赤血球造血刺激因子製剤(ESA)と低酸素誘導因子プロリン水酸化酵素(HIF-PH)阻害薬. Medical Practice. 2024. 41. 9. 1398-1402
-
金 沙織, 豊原 敬文, 田中 哲洋. 【動脈・静脈の疾患2024(下)-最新の診断・治療動向-】動脈・静脈の疾患(臓器別)腎臓疾患 腎臓脈狭窄症. 日本臨床. 2024. 82. 増刊5 動脈・静脈の疾患2024(下). 206-211
-
石岡 広崇, 田中 哲洋. 【透析患者の心不全パンデミックに立ち向かう】腎性貧血と鉄欠乏による循環動態への影響. 臨床透析. 2024. 40. 5. 490-495
-
玉懸 直人, 田中 哲洋. 【急性腎障害の最新トレンド】急性腎障害から慢性腎臓病への移行. 臨床透析. 2024. 40. 4. 388-393
more... Books (1): - 腎機能低下時の薬剤ポケットマニュアル
中外医学社 2019 ISBN:9784498117075
Lectures and oral presentations (322): -
COVID-19流行期の慢性透析患者の体液組成、栄養指標の変化の前方視的観察研究
(第15回透析運動療法研究会 2025)
-
感染症に伴う血圧低下による透析困難症に対し少量バゾプレシン持続投与した1例
(第52回宮城県腎不全研究会 2024)
-
手術不能な続発性副甲状腺機能亢進症症例に対してウパシカルセト+エテルカルセチド併用でコントロールできた1例
(第52回宮城県腎不全研究会 2024)
-
腎性貧血治療におけるHIF-PH阻害薬への期待と位置づけ
(第51回千葉県透析研究会 2024)
-
無症候性腹膜透析関連腹膜炎を繰り返した一例
(第30回日本腹膜透析医学会学術集会・総会 2024)
more... Education (2): - 2005 - The University of Tokyo Graduate School of Medicine
- 1997 - The University of Tokyo Faculty of Medicine School of Medicine
Work history (8): - 2024/04 - 現在 Tohoku University Department of Nephrology Graduate School of Medicine
- 2022/03 - 2024/03 Tohoku University
- 2020/01 - 2022/02 The University of Tokyo Faculty of Medicine University Hospital Nephrology and Endocrinology
- 2015/11 - 2019/12 The University of Tokyo Faculty of Medicine University Hospital Nephrology and Endocrinology
- 2013/02 - 2015/10 The University of Tokyo Faculty of Medicine University Hospital Nephrology and Endocrinology
- 2009/04 - 2013/01 The University of Tokyo Division for Health Service Promotion
- 2006/01 - 2008/03 ドイツ・エアランゲン大学 腎臓・高血圧内科 研究員
- 1999/06 - 2001/05 三井記念病院 内科・腎センター 医員
Show all
Committee career (3): - 2020 - 現在 腎不全研究会 世話人
- 2018/04 - 現在 日本腎臓学会 教育・専門医制度委員会
- 2018 - 2022/02 日本腎臓病協会 慢性腎臓病対策部会 東京ブロック城北地区
Awards (1): Association Membership(s) (13):
The Japan Endocrine Society
, 日本糖尿病学会
, 日本高血圧学会
, 日本透析医学会
, 日本腎臓学会
, 日本内科学会
, 日本鉄バイオサイエンス学会
, 日本腎臓病協会
, 日本臨床分子医学会
, 日本分子生物学会
, 日本腎臓リハビリテーション学会
, アメリカ腎臓学会
, 国際腎臓学会
Return to Previous Page